• FDA Library Screening Finds Four MERS-CoV Inhibitors

  2026-09-03

  de Wilde and colleagues screened an FDA-approved compound collection and identified chloroquine, chlorpromazine, loperamide, and Lopinavir as low-micromolar inhibitors of MERS-CoV replication in cell culture. The study established a practical repurposing framework and showed activity across additional coronaviruses, while leaving questions about mechanism, in vivo efficacy, and clinical relevance unresolved.

• Kir2.1 Inhibition in Pulmonary Vascular Remodeling

  2026-09-03

  The reference study identifies KIR2.1 as a regulator of pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension models. Its pharmacological experiments connect KIR2.1 inhibition with reduced OPN and PCNA expression and suppression of TGF-β1/SMAD2/3 signaling, providing a mechanistic framework for cardiovascular ion channel research.

• WSP-5: Making the H2S Deficit Visible

  2026-09-02

  A translational perspective on how WSP-5, or Washington State Probe-5, can connect deficient hydrogen sulfide biology with real-time cellular evidence in diabetic cardiomyopathy and related disease models.

• Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain

  2026-09-02

  Schwarz et al. show that geraniol, linalool, β-pinene, α-humulene, and β-caryophyllene produce antinociception in mouse pain models through adenosine A2A receptor signaling rather than an assumed cannabinoid-receptor mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cellular assays, binding studies, and modeling provides a mechanistic framework for evaluating non-rewarding terpene analgesics.

• YC-1: Translational Control of Hypoxia Biology

  2026-09-01

  YC-1 is more than a conventional HIF-1α research tool: its soluble guanylyl cyclase activity and post-transcriptional suppression of HIF-1α create an opportunity to connect hypoxia signaling, vascular biology, tumor angiogenesis inhibition, and cancer research. This thought-leadership guide outlines how translational teams can use YC-1 while separating pathway effects, strengthening assay design, and avoiding overinterpretation.

• TMRE Mitochondrial Membrane Potential Assay Kit

  2026-09-01

  The TMRE mitochondrial membrane potential assay kit uses a Tetramethylrhodamine ethyl ester mitochondrial probe to quantify changes in ΔΨm through red fluorescence. K2233 combines TMRE, dilution buffer, and CCCP control for mitochondrial function analysis, apoptosis studies, and mitochondrial depolarization measurement.

• GTP Solution for Precision mRNA Workflows

  2026-08-31

  A controlled 100 mM GTP stock supports reproducible in vitro transcription, from p21 mRNA production to lipid nanoparticle testing. This practical guide connects nucleotide handling and assay optimization with the localized mRNA-LNP strategy reported for bladder cancer.

• Precision PCR for Neurodegeneration Research

  2026-08-31

  A translational framework for using high-fidelity PCR to validate the genetic and molecular circuitry linking early pheromone perception to adult neurodegeneration in C. elegans.

• Amitriptyline HCl in BBB Assay Design

  2026-08-30

  Amitriptyline HCl can serve as a mechanistic probe for receptor biology and CNS assay interpretation. This guide connects B2231 handling with a high-throughput BBB model, emphasizing lysosomal trapping, efflux, recovery, and decision quality rather than simple permeability ranking.

• Ion Supplementation Improves CPP Nucleic Acid Delivery

  2026-08-29

  The reference study shows that inorganic ions can tune the size, charge, stability, and biological performance of cell-penetrating peptide–nucleic acid nanoparticles. Its central implication is that ion selection can improve productive delivery primarily by promoting endosomal escape, rather than simply increasing cellular internalization.

• Mithramycin A in Transcription Assays

  2026-08-28

  Mithramycin A converts metal-dependent binding to G-C-rich DNA into a practical perturbation tool for c-myc, differentiation, and transcription studies. This workflow-focused guide also shows how to evaluate its carefully bounded use in doxorubicin-induced cardiac injury models without confusing a broad DNA-binding probe with a pathway-specific inhibitor.

• Senescent Beta Cells and Type 1 Diabetes: Study Insights

  2026-08-28

  Thompson et al. showed that a subset of pancreatic beta cells becomes senescent during type 1 diabetes and develops a secretory phenotype that may intensify immune-mediated damage. By targeting the Bcl-2-dependent survival of these cells, the study preserved beta-cell mass and prevented diabetes in NOD mice, providing a mechanistic basis for senolytic research in T1D.

• DiD (DiDC 18 (5)) for Membrane Tracking

  2026-08-27

  DiD (DiDC 18 (5)) delivers far-red plasma membrane labeling for cell migration tracking, neuronal tracing, fusion assays, and imaging in autofluorescent tissues. This practical guide connects its workflow to macrophage-centered diabetic periodontitis research while clearly separating validated product properties from assay-development recommendations.

• Sodium-Driven Mitochondrial Energy Failure in NECSO

  2026-08-27

  Qiao et al. identify a mechanistic link between TRPM4-dependent sodium influx, mitochondrial ion imbalance, impaired oxidative metabolism, and necrosis by sodium overload. The study shows why mitochondrial energy measurements, including membrane-potential readouts, can complement endpoint cell-death assays when investigating sodium-driven injury.

• Maraviroc: A CCR5-Centered Assay Strategy

  2026-08-26

  Maraviroc and UK-427857 enable precise interrogation of CCR5 biology across HIV-1 entry and neuroinflammation models. This guide focuses on a time- and compartment-aware assay strategy that connects receptor pharmacology with inflammatory readouts without overstating translational evidence.

7986 records 1/533 page Next 12345 下5页 Last page